TNF and autoimmune disease: Etanercept, a recombinant soluble receptor to TNF‐α that is used for treating autoimmune diseases, led to significantly reduced periodontal inflammation, infiltration of neutrophils, and iNOS levels in rats with experimentally induced periodontitis (Di Paola et al., 2007).